| Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers (NCT02253901) | Boehringer Ingelheim | 2005-03-01 |
| Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia (NCT02245529) | Boehringer Ingelheim | 2005-03-01 |
| Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers (NCT02214901) | Boehringer Ingelheim | 2005-03-01 |
| Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue (NCT00144235) | Boehringer Ingelheim | 2005-03-01 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female Volunteers (NCT02171780) | Boehringer Ingelheim | 2005-02-01 |
| Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers (NCT02262624) | Boehringer Ingelheim | 2005-02-01 |
| The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects (NCT00146289) | Boehringer Ingelheim | 2005-02-01 |
| An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension (NCT00904215) | Boehringer Ingelheim | 2005-02-01 |
| Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers (NCT02257021) | Boehringer Ingelheim | 2005-02-01 |
| Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir (NCT02253836) | Boehringer Ingelheim | 2005-01-01 |
| Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy (NCT00144222) | Boehringer Ingelheim | 2005-01-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers (NCT02256761) | Boehringer Ingelheim | 2005-01-01 |
| Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients (NCT00144300) | Boehringer Ingelheim | 2005-01-01 |
| Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension (NCT02242383) | Boehringer Ingelheim | 2005-01-01 |
| Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders (NCT02266524) | Boehringer Ingelheim | 2005-01-01 |
| Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers (NCT02245451) | Boehringer Ingelheim | 2005-01-01 |
| BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171650) | Boehringer Ingelheim | 2004-12-01 |
| Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma (NCT00152984) | Boehringer Ingelheim | 2004-12-01 |
| Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection (NCT00097799) | Boehringer Ingelheim | 2004-12-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin (NCT02170909) | Boehringer Ingelheim | 2004-12-01 |
| Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours (NCT02171702) | Boehringer Ingelheim | 2004-11-01 |
| Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement (NCT00152971) | Boehringer Ingelheim | 2004-11-01 |
| Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers (NCT02254226) | Boehringer Ingelheim | 2004-11-01 |
| Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery (NCT00168818) | Boehringer Ingelheim | 2004-11-01 |
| RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery (NCT00168805) | Boehringer Ingelheim | 2004-11-01 |
| Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171728) | Boehringer Ingelheim | 2004-11-01 |
| Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma (NCT00096616) | Boehringer Ingelheim | 2004-11-01 |
| A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120 (NCT00715403) | Boehringer Ingelheim | 2004-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects (NCT02173665) | Boehringer Ingelheim | 2004-10-01 |
| A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®) (NCT00257452) | Boehringer Ingelheim | 2004-10-01 |
| Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects (NCT02182271) | Boehringer Ingelheim | 2004-10-01 |
| Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy Subjects (NCT02256774) | Boehringer Ingelheim | 2004-10-01 |
| Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers (NCT02262598) | Boehringer Ingelheim | 2004-09-01 |
| Relative Bioavailability of Ambroxol Hydrochloride of Soft Pastilles Compared to Ambroxol Hydrochloride Syrup in Healthy Male and Female Volunteers (NCT02194270) | Boehringer Ingelheim | 2004-09-01 |
| Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension (NCT00638911) | Boehringer Ingelheim | 2004-09-01 |
| Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients (NCT02242851) | Boehringer Ingelheim | 2004-09-01 |
| Study to Evaluate the Effect Single and Multiple Oral Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Amitriptyline and Nortriptyline in Healthy Male and Female Subjects (NCT02256878) | Boehringer Ingelheim | 2004-08-01 |
| Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome (NCT00152997) | Boehringer Ingelheim | 2004-08-01 |
| Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects (NCT02184338) | Boehringer Ingelheim | 2004-08-01 |
| Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit (NCT02211859) | Boehringer Ingelheim | 2004-08-01 |
| BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit (NCT02211872) | Boehringer Ingelheim | 2004-08-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male Volunteers (NCT02259764) | Boehringer Ingelheim | 2004-08-01 |
| Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection (NCT02254707) | Boehringer Ingelheim | 2004-07-01 |
| Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects. (NCT02170974) | Boehringer Ingelheim | 2004-07-01 |
| Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux (NCT02211898) | Boehringer Ingelheim | 2004-07-01 |
| A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis (NCT00239395) | Boehringer Ingelheim | 2004-07-01 |
| A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis (NCT00239382) | Boehringer Ingelheim | 2004-07-01 |
| A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions (NCT00144248) | Boehringer Ingelheim | 2004-06-25 |
| Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin (NCT02170844) | Boehringer Ingelheim | 2004-06-01 |
| 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension (NCT00153049) | Boehringer Ingelheim | 2004-06-01 |
| Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers (NCT02260050) | Boehringer Ingelheim | 2004-06-01 |
| Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression (NCT02191202) | Boehringer Ingelheim | 2004-06-01 |
| Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD Patients (NCT02242279) | Boehringer Ingelheim | 2004-06-01 |
| Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease (NCT00106821) | Boehringer Ingelheim | 2004-06-01 |
| Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers (NCT02261090) | Boehringer Ingelheim | 2004-06-01 |
| Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options (NCT00144287) | Boehringer Ingelheim | 2004-05-01 |
| Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects (NCT02262793) | Boehringer Ingelheim | 2004-05-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers (NCT02254122) | Boehringer Ingelheim | 2004-05-01 |
| An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options. (NCT00933205) | Boehringer Ingelheim | 2004-05-01 |
| Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) (NCT02244346) | Boehringer Ingelheim | 2004-05-01 |
| Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects (NCT02262650) | Boehringer Ingelheim | 2004-04-01 |
| Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet (NCT02238223) | Boehringer Ingelheim | 2004-04-01 |
| Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous Insufficiency (NCT02191254) | Boehringer Ingelheim | 2004-04-01 |
| Safety, Tolerability and Pharmacokinetics of Oral BIBP 5371 CL in Healthy Male and Female Volunteers (NCT02256709) | Boehringer Ingelheim | 2004-04-01 |
| Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure (NCT02232581) | Boehringer Ingelheim | 2004-04-01 |
| Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) (NCT00133198) | Boehringer Ingelheim | 2004-04-01 |
| Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients (NCT00129038) | Boehringer Ingelheim | 2004-04-01 |
| 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) (NCT00144196) | Boehringer Ingelheim | 2004-03-11 |
| Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171663) | Boehringer Ingelheim | 2004-03-01 |
| Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients (NCT00620516) | Boehringer Ingelheim | 2004-03-01 |
| Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers (NCT02264028) | Boehringer Ingelheim | 2004-03-01 |
| Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study (NCT00612885) | Boehringer Ingelheim | 2004-03-01 |
| Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease (NCT02231372) | Boehringer Ingelheim | 2004-03-01 |
| A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension (NCT00133185) | Boehringer Ingelheim | 2004-03-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers (NCT02259894) | Boehringer Ingelheim | 2004-03-01 |
| Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) (NCT02244333) | Boehringer Ingelheim | 2004-02-01 |
| Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa (NCT00613301) | Boehringer Ingelheim | 2004-02-01 |
| Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease (NCT02248181) | Boehringer Ingelheim | 2004-02-01 |
| A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients. (NCT00144105) | Boehringer Ingelheim | 2004-02-01 |
| Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers (NCT02259933) | Boehringer Ingelheim | 2004-02-01 |
| Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers (NCT02253914) | Boehringer Ingelheim | 2004-02-01 |
| Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity (NCT02259751) | Boehringer Ingelheim | 2004-02-01 |
| Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole (NCT00615914) | Boehringer Ingelheim | 2004-02-01 |
| Special Survey on PD Patients With Renal Dysfunction (NCT00613756) | Boehringer Ingelheim | 2004-02-01 |
| Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial (NCT00157261) | Boehringer Ingelheim | 2004-01-01 |
| Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease (NCT02231905) | Boehringer Ingelheim | 2004-01-01 |
| Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases (NCT02184065) | Boehringer Ingelheim | 2004-01-01 |
| Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease (NCT02231359) | Boehringer Ingelheim | 2004-01-01 |
| A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) (NCT00152958) | Boehringer Ingelheim | 2004-01-01 |
| Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers (NCT02273531) | Boehringer Ingelheim | 2004-01-01 |
| Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation (NCT02172508) | Boehringer Ingelheim | 2004-01-01 |
| Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine (NCT02264041) | Boehringer Ingelheim | 2004-01-01 |
| Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food (NCT02256787) | Boehringer Ingelheim | 2004-01-01 |
| Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers (NCT02264015) | Boehringer Ingelheim | 2004-01-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers (NCT02262780) | Boehringer Ingelheim | 2003-12-01 |
| Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 (NCT00157248) | Boehringer Ingelheim | 2003-12-01 |
| Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers (NCT02259920) | Boehringer Ingelheim | 2003-12-01 |
| Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children (NCT00076999) | Boehringer Ingelheim | 2003-11-01 |
| A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) (NCT00168792) | Boehringer Ingelheim | 2003-11-01 |
| A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) (NCT00239421) | Boehringer Ingelheim | 2003-11-01 |